Thrombotic events in patients with antiphospholipid syndrome treated with rivaroxaban: a series of eight cases

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

Spiros Miyakis, Michael D. Lockshin, Tatsuya Atsumi et al. · Journal of Thrombosis and Haemostasis · 2006 · 7K citations · Full text

Lipid Disorder, International Consensus Statement, Cardiovascular Disease +9

The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome

Munther A. Khamashta, María José Cuadrado, F Mujić et al. · New England Journal of Medicine · 1995 · 1.5K citations · Full text

Failure of dabigatran and rivaroxaban to prevent thromboembolism in antiphospholipid syndrome: a case series of three patients

Jordan K. Schaefer, Robert D. McBane, David M. Black et al. · Thrombosis and Haemostasis · 2014 · 90 citations

Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE

Hannah Cohen, Caroline J Doré, Simon Clawson et al. · Lupus · 2015 · 74 citations · Full text

False-positive lupus anticoagulant in patients receiving rivaroxaban

Tadeusz Góralczyk, Teresa Iwaniec, Ewa Wypasek et al. · Blood Coagulation & Fibrinolysis · 2014 · 28 citations · Full text

Thrombosis, Venous Thrombosis, Autoimmune Disease +15